Compare BHVN & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHVN | AOD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 970.0M |
| IPO Year | 2017 | N/A |
| Metric | BHVN | AOD |
|---|---|---|
| Price | $10.54 | $9.66 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $29.79 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 423.5K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.95% |
| EPS Growth | N/A | ★ 213.63 |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | ★ $72,962,082.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,219.74 | N/A |
| P/E Ratio | ★ N/A | $4.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.48 | $6.99 |
| 52 Week High | $45.87 | $9.14 |
| Indicator | BHVN | AOD |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 60.20 |
| Support Level | $8.29 | $9.57 |
| Resistance Level | $10.18 | $9.74 |
| Average True Range (ATR) | 0.76 | 0.10 |
| MACD | 0.34 | 0.03 |
| Stochastic Oscillator | 90.59 | 85.59 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.